Linzess denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for linzess are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Linzess on Medical-Necessity Grounds

Linzess (linaclotide) is an FDA-approved treatment for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Aetna's medical-necessity denials for Linzess typically arise when the clinical file does not clearly document that the patient's condition has been formally diagnosed, that the severity warrants prescription therapy, or that appropriate prior treatments have been tried and failed. Aetna applies its own coverage criteria — which you should download directly from the Aetna website or request in writing — alongside the FDA-approved prescribing information.

## Why This Denial Is Appealable

A medical-necessity denial is not final. Federal law gives you the right to a full internal appeal and, if that fails, an independent external review. Under ACA §2719, non-grandfathered health plans must provide access to external review by an accredited Independent Review Organization (IRO). Under ERISA §503, employer-sponsored plans must provide a full-and-fair review. You generally have approximately 180 days from the denial notice to file an internal appeal, and external review must be requested within four months of exhausting internal appeals. An expedited (72-hour) review is available when your health would be seriously jeopardized by delay.

## The Concrete Appeal Process

1. Request the denial in writing — obtain Aetna's specific denial letter stating every reason and every criterion not met. 2. Request Aetna's coverage policy — ask for the specific Clinical Policy Bulletin governing Linzess so you can respond to each criterion point by point. 3. File the internal appeal — submit within the deadline shown on the denial notice. 4. Request external review — if the internal appeal is denied, immediately request IRO review.

## Documentation to Gather

• Formal diagnosis: physician notes confirming diagnosis of IBS-C or CIC with documented symptom history and severity.
• Prior-treatment history: names of all previously tried therapies, dates of use, doses tried, and documented outcomes or adverse effects — with dates.
• Clinical severity: chart notes describing the impact on daily function, quality of life, or any complications.
• Prescriber's medical-necessity letter: a detailed letter from the treating physician explaining why Linzess is medically necessary for this patient at this time, referencing the applicable guideline organization (such as the American College of Gastroenterology) without fabricating statistics.
• Relevant lab or diagnostic results supporting the diagnosis.

## Criteria-Mapping Structure

Pull every numbered requirement from Aetna's Clinical Policy Bulletin and the FDA-approved Linzess prescribing label. For each requirement, write one sentence citing the exact chart fact that satisfies it — date, source document, and clinical finding. If a requirement mentions prior failed therapies, list each therapy by name with the date it was tried and the documented reason it was inadequate. This direct mapping is the single most effective tool in a medical-necessity appeal.